Brian C. Stephenson, Secretary, Treasurer & CFO at BridgeBio Pharma, Inc. (BBIO), sold 67,681 shares at $29.10 ($2.0M) on 2023-11-17, disclosed to the SEC on 2023-11-20.
Scheduled sale ($2.0M) by Secretary, Treasurer & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.86 | 22,311 | $644K | 32.8% |
| 2 | $29.10 | 22,685 | $660K | 33.6% |
| 3 | $29.10 | 22,685 | $660K | 33.6% |
| Total | $29.02 avg | 67,681 | $2.0M | 100% |
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |